Cargando…
CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1
Tumor metastasis remains an obstacle in cancer treatment and is responsible for most cancer-related deaths. Nm23-H1 is one of the first metastasis suppressor proteins discovered with the ability to inhibit metastasis of many cancers including breast, colon, and liver cancer. Although loss of Nm23-H1...
Autores principales: | Wong, Ka Ming, Song, Jiaxing, Wong, Yung H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804126/ https://www.ncbi.nlm.nih.gov/pubmed/33436746 http://dx.doi.org/10.1038/s41598-020-79869-9 |
Ejemplares similares
-
RGS19 upregulates Nm23-H1/2 metastasis suppressors by transcriptional activation via the cAMP/PKA/CREB pathway
por: Li, Yuanjun, et al.
Publicado: (2017) -
Involvement of CTCF in transcription regulation of EGR1 at early G1 phase as an architecture factor
por: Sekiya, Takeshi, et al.
Publicado: (2019) -
Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1
por: She, Shangyang, et al.
Publicado: (2010) -
Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.
por: Watanabe, J., et al.
Publicado: (1995) -
Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation
por: Kim, Bokyung, et al.
Publicado: (2021)